Locations:
Min Investment:
Max Investment:
Target Investment:
2024
Majesty Therapeutics is a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutics and companion diagnostics for the treatment of immune-mediated diseases.
2017
2017
Allele Capital is a merchant bank and strategic advisory firm that provides venture capital and private equity financing to private and small-cap public life sciences companies. Allele works in partnership with its clients to provide a suite of value-added services which include strategic advisory, proprietary capital, and non-proprietary capital through its executing investment bank, Wilmington Capital Securities, LLC a registered Broker-Dealer, Member FINRA and SIPC. All business executed through Wilmington is subject to FINRA and SEC rules and regulations. Whether through advisory or capital raising activities, Allele leverages its extensive proprietary network of advisors, C-Suite level management relationships and key opinion leaders (KOLs) for the benefit of its corporate and investment partners. Allele's principals' comprehensive experience in private-to-public and public venture process for small life sciences companies has resulted in significant shareholder equity and valuations of over $2 billion. www.allelecapital.com
2022
Allele Communications is a fully-integrated communications firm that provides effective and impactful public relations, social and digital media, and traditional media solutions for companies in the life sciences and medical device industries. www.allelecommunications.com
2021
Praesidia is developing drugs with an increased therapeutic window through proprietary organ and cell-specific delivery, especially across the blood-brain barrier.
2006 - 2017
2006 - 2017
Noble Life Science Partners, a division of Noble Financial Capital Markets, is focused on investment banking, merchant banking and capital markets support for companies in the biotechnology, specialty pharmaceuticals and medical technology industries.
2003 - 2006
2003 - 2006
Founding Partner and Director of independent equity research and trading boutique focused exclusively on U.S. based companies in the Biotechnology, Medical Technology and Specialty Pharmaceutical industries.
2000 - 2003
2000 - 2003
Highest grossing institutional salesperson at firm focused exclusively on short biased research and trading in the healthcare industry.